Valeria G Nicolini

This inventor holds 17 USPTO granted patents and 18 published patent applications, plus 3 CIPO patents and 9 EPO patents. Top assignees: Roche Glycart Ag, Hoffmann-La Roche Inc.. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valeria G Nicolini. Retrieved from https://idiyas.com/inventor/valeria-g-nicolini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 18)

% Patents Active = 88.2

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 9 (Patent Applications = 18)

Average Co-Inventor Count = 7.0

ph-index = 7

Forward Citations = 192(Granted Patents)

Location History:

Erlenbach/ZH, CH (2019 - 2021)
Erlenbach, CH (2015 - 2022)
Schlieren, CH (2022 - 2024)

Company Filing History:

Hoffmann-La Roche Inc.

patents

Years Active: 2015-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473373 - BISPECIFIC ANTIBODY MOLECULES BINDING TO CD3 AND EGFRvIII (2025-11-18),

2. 12286486 - Anti-FAP antibodies and methods of use (2025-04-29),

3. 12023368 - Immunoconjugates (2024-07-02),

4. 11865082 - Combination therapy of PD-1-targeted IL-2 variant immunocytokines and antibodies against human PD-L1 (2024-01-09),

5. 11672858 - Bispecific antibody molecules binding to CD3 and TYRP-1 (2023-06-13),

6. 11591397 - Bispecific antibody molecules binding to CD3 and EGFRvIII (2023-02-28),

7. 11413331 - Immunoconjugates (2022-08-16),

8. 11332545 - Anti-FAP antibodies and methods of use (2022-05-17),

9. 11111312 - Mutant interleukin-2 polypeptides (2021-09-07),

10. 10603360 - Combination IL-2 immunoconjugate therapy (2020-03-31),

11. 10577429 - Anti-FAP antibodies and methods of use (2020-03-03),

12. 10323098 - Mutant interleukin-2 polypeptides (2019-06-18),

13. 10253110 - Anti-FAP antibodies and methods of use (2019-04-09),

14. 10184009 - Mutant interleukin-2 polypeptides (2019-01-22),

15. 9526797 - Combination IL-2 immunoconjugate therapy (2016-12-27),

Title: Inventor Valeria G Nicolini - Pioneer in Nanotechnology

Introduction: Valeria G Nicolini, a distinguished inventor hailing from Erlenbach, Switzerland, is renowned for her groundbreaking work in the field of nanotechnology.

Latest Patents: Valeria G Nicolini holds several patents in the field of nanotechnology, including advancements in nanomedicine, nanobiotechnology, and nanotoxicology.

Career Highlights: With a career spanning over two decades, Valeria G Nicolini has made significant contributions to the scientific community through her innovative research and patented inventions. Her work has paved the way for advancements in various industries, from healthcare to environmental science.

Collaborations: Throughout her career, Valeria G Nicolini has collaborated with leading research institutions, universities, and companies worldwide to further the development and application of nanotechnology in real-world settings. Her collaborative efforts have resulted in groundbreaking discoveries and technological innovations.

Conclusion: Valeria G Nicolini's dedication to pushing the boundaries of nanotechnology and her passion for scientific exploration have solidified her reputation as a pioneering inventor in the field. Her contributions continue to inspire future generations of innovators and researchers in the ever-evolving landscape of nanotechnology.

Profile summary based on public USPTO records.